Public company info
Input the stock code or the company name     Search  
 


 Stock code   03681 
 Company name  SinoMab BioScience Limited
 Region  Hong Kong
 Type  MB
 Website  
 Quote  0.0 

Company profile  |  Business review  |  Prospect  |  Latest results  |  Financial ratios
Income statement  |  Cash flow statement  |  Balance sheet  |  Entitlement
Disclosure of interest  |  Quote

 Related stock news
  中國抗體SM17治療特應性皮炎中國2...  2026-04-01T  
  中國抗體：SM17完成中國給藥途徑轉...  2026-03-25T  
  《業績》中國抗體全年虧損收窄至1.0...  2026-03-24T  
  中國抗體SM17治療炎症性腸病臨床試...  2026-02-24T  
  中國抗體-B發表SM17臨床前研究 ...  2026-02-20T  
  中國抗體SM17針對炎症性腸病新藥研...  2025-12-11T  
  中國抗體SM17皮下注射劑實驗完成首...  2025-10-14T  
  《業績》中國抗體中期虧損收窄至4,9...  2025-08-31T  
  中國抗體與中山大學香港高等研究院訂立...  2025-08-12T  
  中國抗體折讓16.12%發新股 集資...  2025-07-22T  
  Search   More 
 Latest News
  南向資金今日淨賣出超106億 港元 ...  2026-08-19T17:  
  ...瑞銀:黃金中期漲勢未完 預計明...  2026-08-19T17:  
  騰訊斥約3億元回購67.3萬股  2026-08-19T  
  《業績》冠君產業信託中期扭虧賺5.4...  2026-08-19T  
  紐約匯市: 美元 隨油價上漲 日元 ...  2026-08-19T05:  
  A50 增強 ETF 富國(5632...  2026-08-19T03:  
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.